Skip to main content

Table 2 Univariate and multivariate analysis of clinicopathological variables and TMEM176B expression associated with overall survival

From: Transmembrane protein 176B regulates amino acid metabolism through the PI3K-Akt-mTOR signaling pathway and promotes gastric cancer progression

Parameters

Univariate analysis

Multivariate analysis

HR (95% CI)

P-value

HR (95% CI)

P-value

Gender (male vs female)

0.910(0.511–1.622)

0.750

  

Age (years) (< 61 vs ≥ 61)

1.272 (0.732–2.212)

0.393

  

Tumor location (upper vs middle + lower)

1.153 (0.643–2.068)

0.634

  

Tumor size (cm) (< 6 vs ≥ 6)

0.824 (0.482–1.408)

0.479

  

Depth of invasion (T1 + T2 vs T3 + T4)

1.578 (0.827–3.008)

0.166

  

Lymph node metastasis (absent vs present)

3.713 (1.474–9.353)

0.005a

3.345 (1.103–10.145)

0.033a

Differentiation (well + moderate vs poor)

1.648 (0.918–2.957)

0.094

  

TNM stage (I + II vs III + IV)

1.967 (1.034–3.739)

0.039a

0.844 (0.386–1.843)

0.670

TMEM176B expression (low vs high)

2.515 (1.452–4.357)

0.001a

2.124 (1.204–3.750)

0.009a

  1. aStatistically significant (P < 0.05)